Patents by Inventor Sun-Ho HAN

Sun-Ho HAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Blood biomarker for discerning beta amyloid accumulation in brain
    Patent number: 11193946
    Abstract: Provided concerns a blood biomarker for discerning the cerebral deposition of amyloid beta, which is a causative material of Alzheimer's dementia. A marker according to the subject matter can conveniently and rapidly predictive of cerebral amyloid beta accumulation by use of a blood and can be effectively used in diagnosing relevant diseases including mild cognitive impairment at a preclinical level.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: December 7, 2021
    Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Inhee Mook, Sun-Ho Han, Jong-Chan Park
  • BLOOD BIOMARKER FOR DISCERNING BETA AMYLOID ACCUMULATION IN BRAIN
    Publication number: 20210215719
    Abstract: Provided concerns a blood biomarker for discerning the cerebral deposition of amyloid beta, which is a causative material of Alzheimer's dementia. A marker according to the subject matter can conveniently and rapidly predictive of cerebral amyloid beta accumulation by use of a blood and can be effectively used in diagnosing relevant diseases including mild cognitive impairment at a preclinical level.
    Type: Application
    Filed: March 22, 2018
    Publication date: July 15, 2021
    Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Inhee MOOK, Sun-Ho HAN, Jong-Chan PARK
  • Method for clinically and pathologically monitoring Alzheimer's disease through concentration of amyloidbeta in plasma
    Patent number: 10989720
    Abstract: Provided is a method for quantifying A? in plasma by treating the plasma with MPP and/or TCEP, and a method for diagnosing, using the quantifying method, whether or not clinical cognitive deterioration and pathological A? accumulation occur. Through cut-off values of measured values measured by the method for quantifying A? according to the present subject matter, it is possible to identify normal, MCI and AD subjects and determine whether or not accumulation of A? in the brain occurs, and it is possible to predict progression to AD.
    Type: Grant
    Filed: April 30, 2016
    Date of Patent: April 27, 2021
    Assignee: Seoul National University R&DB Foundation
    Inventors: Inhee Mook, Jong-Chan Park, Hyun Jin Cho, Sun-Ho Han
  • METHOD FOR CLINICALLY AND PATHOLOGICALLY MONITORING ALZHEIMER'S DISEASE THROUGH CONCENTRATION OF AMYLOIDBETA IN PLASMA
    Publication number: 20180136234
    Abstract: Provided is a method for quantifying A? in plasma by treating the plasma with MPP and/or TCEP, and a method for diagnosing, using the quantifying method, whether or not clinical cognitive deterioration and pathological A? accumulation occur. Through cut-off values of measured values measured by the method for quantifying A? according to the present subject matter, it is possible to identify normal, MCI and AD subjects and determine whether or not accumulation of A? in the brain occurs, and it is possible to predict progression to AD.
    Type: Application
    Filed: April 30, 2016
    Publication date: May 17, 2018
    Applicant: Seoul National University R&DB Foundation
    Inventors: Inhee MOOK, Jong-Chan PARK, Hyun Jin CHO, Sun-Ho HAN